Managing antipthospholipid antibodies and antiphospholipid syndrome in children

Haematologica

Volumn 91, Issue 12, 2006, Pages 1674-1680

  Kamat, Anil V ^a   D'Cruz, David P ^c   Hunt, Beverly J ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c NONE

Author keywords

Antiphospholipid antibodies; Chidren; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; HEPARIN; HYDROXYCHLOROQUINE; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; TINZAPARIN; WARFARIN; ANTICOAGULANT AGENT;

ADOLESCENT; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOLYTIC ANEMIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; MALE; MULTICENTER STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; PERONEUS NERVE PARALYSIS; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; BLOOD; CHILD; DISEASE MANAGEMENT; REVIEW;

ADOLESCENT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CHILD; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE;

EID: 33845964142     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, et al. Venous thromboembolic complications (VTE) in children: first analysis of the Canadian Registry of VTE. Blood 1994; 83:1251-7.
2. Wise RC, Todd JK. Spontaneous lower extremity venous thrombosis in children. AJDC 1973;126:766-9.
3. Nowak-Gottl U, Koch HG, Aschka I, Kohlhase B, Vielhaber H, Kurlemann G, et al. Resistance to activated protein C (AFCR) in children with venous or arterial thromboembolism. Br J Haematol 1996;92:992-8.
4. Broderick J, Talbot GT, Prenger E. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 1993;8:250-5.
5. Williams LS, Garg BP, Cohen M, Fleck JD, Biller J. Subtypes of ischemic stroke in children and young adults. Neurology 1997;49:1541-5.
6. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GRV. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;2:1211-4.
7. Hughes GRV, Harris AE, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986;13:486-9.
8. Asherson RA, Cervera R, Piette JC, Shonfeld Y. Milestones in the antiphospholipid syndrome. The Antiphospholipid Syndrome II - Autoimmune Thrombosis 2002:3-9.
9. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, et al. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335:1544-7.
10. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemostas 2006;4:295-306.
11. Vaarala O, Palosuo T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986;1:8-15.
12. Kurugol Z, Vardar F, Ozkinay F, Kavakli K, Ozkinay C. Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection. Acta Paediatrica 2000;89:1186-9.
13. Manco-Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996;128:319-23.
14. Levi M. Measuring activated protein C in plasma to assess its role as a critical modulator of coagulation and inflammation. J Thromb Haemost 2003;1:643-4.
15. Rapizzi E, Ruffati A, Tonello M, Piccoli A, Calligaro A, Sfriso P, et al. Correction or age of anticardiolipin antibodies cutoff points. J Clin Lab Anal 2000;14:87-90.
16. Caporali R, Ravelli A, De Gennaro F, Neirotti G, Montecucco C, Martini A. Prevalence of anticardiolipin antibodies in juvenile arthritis. Ann Rheum Dis 1991;50:599-601.
17. Siamopoulou-Mavridou A, Mavradis AK, Terzoglou C, Filopoulou S, Athanasiadou S, Tzioufas AG. Autoantibodies in Greek juvenile chronic arthritis patients. 1991;9:647-52.
18. Gattorno M, Buoncompagni A, Molinari AC, Barbano GC, Morreale G, Stalla F, et al. Antiphospholipid antibodies in paediatric systemic lupus erythematosis, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Br J Rheumatol 1995;34:873-81.
19. Kontianen S, Miettinen A, Sepala I, Verkasalo M, Maenpaa J. Antiphospholipid antibodies in children. Acta Paediatrica 1996;85:614-5.
20. Serra CRB, Rodrigues SH, Silva NP, Szatajnbok FR, Andrade LEG. Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis. Clin Exp Rheumatol 1999;17:375-80.
21. Male C, Lechner K, Eichinger S, Kyrle PA, Kapiotis S, Wank H et al. Clinical significance of lupus anticoagulants in children. J Pediatr 1999;134:199-205.
22. Gallistl S, Muntean W, Leschnik B & Meyers W. Longer aPPT values in healthy children than in adults: no single cause. Thromb Res 1997;88:355-9.
23. Siemens HJG, Gutsche S, Bruckner S, Bucsky P, Katus HA. Antiphospholipid antibodies in children without and in adults with and without thrombophilia. Thromb Res 2000;98:241-7.
24. Aguilar Franco C, Lucia Cuesta J. Antiphospholipid antibodies in asymptomatic pediatric patients. Anales Espanoles de Pediatria 2001;54:444-9.
25. Ravelli A, Martini A. Antiphospholipid antibody syndrome in pediatric patients. Rheum Dis Clin North Am 1997;23:657-76.
26. Tucker LB. Antiphospholipid antibodies and antiphospholipid syndromes in children. In: Khamashta MA, Editor. Hughes Syndrome, Antiphospholipid Syndrome; London: Springer. 2000. p. 155-66.
27. Uysal Z, Dogu F, Kurekci AE, Culha VK, Deda G, Ekim M, et al. Recurrent arterial thrombosis in a child: primary antiphospholipid antibody syndrome. Pediat Hematol Oncol 2002;19:59-66.
28. Manco-Johnson MJ, Nuss R. Lupus anticoagulant in children with thrombosis. Am J Hematol 1995;48:240-3.
29. Falcini F, Taccetti G, Ermini M, Trapani S, Matucci Cerinic M. Catastrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus. J Rheumatol 1997;24:389-92.
30. Nuss R, Hays T, Manco-Johnson M. Childhood thrombosis. Pediatrics 1995; 96:291-4.
31. Angelini L, Zibordi F, Zorzi G, Nardocci N, Caporali R, Ravelli A, et al. Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood. Neuropediatrics 1996;27:149-53.
32. Angelini L, Granata T, Zibordi F, Binelli S, Zorgi G, Besana C. Partial seizures associated with antiphospholipid antibodies in childhood. Neuropediatrics 1998;29:249-53.
33. Tucker LB. Antiphospholipid syndrome in childhood: the great unknown. Lupus 1994;3:367-9.
34. Ravelli A, Caporali R, Di Fuccia G, Zonta L, Montecucco C, Martini A. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Archiv Pediatr Adolesc Med 1994;148:398-402.
35. Seaman DE, Londino V, Kwoh CK, Medsger TA, Manzi S. Antiphospholipid antibodies in pediatric systemic lupus erythematosis. Pediatrics 1995;96:1040-5.
36. Shergy WJ, Kredich DW, Pisetsky DS. The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosis. Rheumatol 1988;15:1389-94.
37. Montes de Oca MA, Babron MC, Bletry O, Broyer M, Courtecuisse V, Fontaine JL, et al. Thrombosis in systemic lupus erythematosus: a French collaborative study. Archiv Dis Childhood 1991;66:713-7.
38. Molta C, Meyer O, Dosquet C, Montes de Oca M, Babron MC, Danon F, et al. Childhood-onset systemic lupus erythematosis: antiphospholipid antibodies in 37 patients and their first-degree relatives. Pediatrics 1993;92:849-53.
39. Massengill SF, Hedrick C, Ayoub EM, Sleasman JW, Kao KJ. Antiphospholipid antibodies in pediatric lupus nephritis. Am J Kidney Dis 1997;29:355-61.
40. Berube C, Mitchell L, Silverman E, David M, Saint Cyr C, Laxer R, et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosis: a cross-sectional study. Pediatr Res 1998;44:351-6.
41. Gedalia A, Molina JF, Garcia CO, Doggett S, Espinoza LR, Gharavi AE. Anticardiolipin antibodies in childhood rheumatic disorders. Lupus 1998;7:551-3.
42. Sugita K, Sato Y, Owada Y, Kurosawa H, Eguchi M. Antiphospholipid antibody syndrome followed by systemic lupus erythematosus in a young male with clinical manifestations since infancy. Pediatr International 2001;43:563-4.
43. Avãin T, Cimaz R, Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 2002;11:4-10.
44. Southwood TR, Roberts-Thomson PJ, Ahern MJ, Shepherd K, McEvoy R, Ziegler JB, et al. Autoantibodies in patients with juvenile chronic arthritis and their immediate family members. Ann Rheum Dis 1990;49:968-72.
45. Male C, Mitchell L, Julian J, Vegh P, Joshua P, Adams M, et al. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 2001;97:844-9.
46. Miller DJ, Maisch SA, Perez MD, Kearney DL, Feltes TF. Fatal myocardial infarction in an 8-year-old girl with systemic lupus erythematosus, Raynaud's phenomenon, and secondary antiphospholipid syndrome. J Rheumatol 1995;22:768-73.
47. Angelini L, Ravelli A, Caporali R, Rumi V, Nardocci N, Martini A. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 1994;94:500-3.
48. Schöning M, Klein R, Krageloh-Mann I, Falck M, Bien S, Berg PA, et al. Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood. Neuropediatrics 1994;25:8-14.
49. Takanashi J, Sugita K, Miyazato S, Sakao E, Miyamoto H, Niimi H. Antiphospholipid antibody syndrome in childhood strokes. Pediatr Neurol 1995;13:323-6.
50. Baca V, Garcia-Ramirez R, Ramirez-Lacayo M, Marquez-Enriquez L, Martinez I, Lavalle C. Cerebral infarction and antiphospholipid syndome in children. J Rheumatol 1996;23:1428-31.
51. Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000;31:1283-88.
52. Pilarska E. The significance of antiphospholipid antibodies in ischemic stroke in children in light of the most current studies (Polish). Przeglad Lekarski 2001;58:22-4.
53. deVeber G, Andrews M, Adams C, Bjornson B, Booth P, Buckley DJ, et al for the Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med 2001;345:417-23.
54. Vlachoyiannopoulos PG, Dimou G & Siamopoulou-Mavridou A. Chorea as a manifestation of the antiphospholipid syndrome in childhood. Clin Exp Rheumatol 1991;9:303-5.
55. Besbas N, Damargue I, Ozen S, Aysun S, Saatci U. Association of antiphospholipid antibodies with systemic lupus erythematosus in a child presenting with chorea: a case report. Eur J Pediat 1994;153:891-3.
56. Okun MS, Jummani RR, Carney PR. Antiphospholipid-associated recurrent chorea and ballism in a child with cerebral palsy. Pediatr Neurol 2000;23:62-3.
57. Al-Matar M, Jaimes J, Malleson P. Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood. Neuropediatrics 2000;31:107-8.
58. Hasegawa M, Yamashita J, Yamashita T, Ikeda K, Fujishima Y, Yamazaki M. Spinal cord infarction associated with primary antiphospholipid syndrome in a young child. Case report. J Neurosurg 1993;79:446-50.
59. Besbas N, Anlar B, Apak A, Kansu T. Optic neuropathy in primary antiphospholipid syndrome in childhood. J Child Neurol 2001;16:690-3.
60. Rumi V, Angelini L, Scioli V, D'Angelo A. Besana C. Primary antiphospholipid syndrome and neurologic events. Pediatr Neurol 1993;9:473-5.
61. Agarwal KS, Puliyel JM, Khanduri U. Sudden onset profound deafness in association with antiphospholipid antibodies in a child with SLE. Indian Pediatrics 2000;37:1274-6.
62. Booth F, Yanofsky R, Ross IB, Lawrence P, Oen K. Primary antiphospholipid syndrome with moyamoya-like vascular changes. Pediatr Neurosurg 1999; 31:45-8.
63. Eriksson K, Peltola J, Keranen T, Haapala AM, Koivikko M. High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases. Epilepsy Res 2001; 46:129-37.
64. Purandare A, Godil MA, Prakash D, Parker R, Zerah M, Wilson TA. Spontaneous adrenal hemorrhage associated with transient antiphospholipid antibody in a child. Clin Pediatr 2001;40:347-50.
65. Becton DL, Stine KC. Transient lupus anticoagulants associated with hemorrhage rather than thrombosis: the hemorrhagic lupus anticoagulant syndrome. J Pediatr 1997;130:998-1000.
66. Yacobovich JR, Uziel Y, Friedman Z, Radnay J, Wolach B. Diffuse muscular haemorrhage as presenting sign of juvenile systemic lupus erythematosus and lupus anticoagulant hypoprothrombinaemia syndrome. Rheumatol 2001;40:585-7.
67. Ohtomo Y, Nagaoka R, Watanabe H, Kaneko K, Ohyama S, Yamashiro Y. Non-lupus nephropathy associated with antiphospholipid antibodies. Pediatr Nephrol 2000;15:136-8.
68. Minisola G, Porzio V, Bancheri C, Ceralli F, Carnabuci A, Onetti Muda A. Atypical renal onset and involvement in primary antiphospholipid syndrome in a child. Clin Exp Rheumatol 1998; 16:102-4.
69. Monastiri K, Selmi H, Tabarki B, Yacoub M, Mahjoub T, Essoussi AS. Primary antiphospholipid syndrome presenting as complicated Henoch-Schonlein purpura. Archiv Dis Childhood 2002;86:132-3.
70. Rongioletti F, Ghio L, Ginevri F, Bleidl D, Rinaldi S, Edefonti A, et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999;140:948-51.
71. Khamashta M, Hunt BJ. Moderate-dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No. J Thromb Haemost 2005;3:844-5.
72. Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. Low-molecular- weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996;128:313-8.
73. Burak CR, Bowen MD, Barron TF. The use of enoxaparin in children with acute, nonhemorrhagic ischemic stroke. Pediatr Neurol 2003;29:295-8.
74. Dix D, Andrew M, Marzinotto V, Charpentier K, Bridge S, Monagle P, et al. The use of low-molecular-weight heparin in pediatric patients: a prospective cohort study. J Pediatr 2000;136:439-5.
75. Punzalan RC, Hillery CA, Montgomery RR, Scott JP, Gill JC. Low-molecular-weight heparin in thrombotic disease in children and adolescents. J Pediatr Hematol Oncol 2000;22:137-42.
76. Albisetti M, Andrew M. Low molecular weight heparin in children. Eur J Pediatr 2002;161:71-7.
77. Buck ML. Anticoagulation with warfarin in infants and children. Ann Pharmacother 1996;30:1316-22.
78. Doyle JJ, Koren G, Cheng MY, Blanchette VS. Anticoagulation with sodium warfarin in children: effect of a loading regimen. J Pediatr 1988;113:1095-7.
79. Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003;349:1133-8.
80. Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 2005; 3:848-53.